| Literature DB >> 14678957 |
Ranjan Ray1, Rafael Cabal-Manzano, Amy R Moser, Todd Waldman, Laurie M Zipper, Achim Aigner, Stephen W Byers, Anna T Riegel, Anton Wellstein.
Abstract
Fibroblast growth factor-binding protein (FGF-BP) releases immobilized FGFs from the extracellular matrix and can function as an angiogenic switch molecule in cancer. Here we show that FGF-BP is up-regulated in early dysplastic lesions of the human colon that are typically associated with a loss of adenomatous polyposis coli and up-regulation of beta-catenin. In addition, FGF-BP expression is induced in dysplastic lesions in ApcMin/+ mice in parallel with the up-regulation of beta-catenin. Also, in cell culture studies FGF-BP is induced by beta-catenin through direct activation of the FGF-BP gene promoter. We conclude that FGF-BP is a target gene of beta-catenin.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14678957
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701